Filter posts

Many Biotechs Still Operating at Low Cash Levels

The percentage of public biotech companies that still operate with less than a year of …

Fewer Public Biotechs in 2010 vs 2008

Back in January 2008, we were tracking 394 “active” public biotech companies. (By “active”, we …

Sector Performance Since the 2007 Market Peak

How does the biotech sector performance rank against the 10 S&P sectors since the S&P500 …

Small Biotechs Spending Less

The median and mean operational cash spending for small public US biotechs (less than 250 …

1 in 4 Biotechs Above 100% - Waterfall Chart YTD

Year to date,  27% of biotech stocks have doubled in price. 65% are in positive …

The Rise and Fall of Undervaluation

If “price to cash” is a usable metric for fair value of a risky biotech …